FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079094787> ?p ?o ?g. }

• W2079094787 endingPage "e0118854" @default.
• W2079094787 startingPage "e0118854" @default.
• W2079094787 abstract "The non-receptor tyrosine kinase ABL drives myeloid progenitor expansion in human chronic myeloid leukemia. ABL inhibition by the tyrosine kinase inhibitor nilotinib is a first-line treatment for this disease. Recently, ABL has also been implicated in the transforming properties of solid tumors, including triple negative (TN) breast cancer. TN breast cancers are highly metastatic and several cell lines derived from these tumors display high invasive activity in vitro. This feature is associated with the activation of actin-rich membrane structures called invadopodia that promote extracellular matrix degradation. Here, we investigated nilotinib effect on the invasive and migratory properties of different TN breast cancer cell lines. Nilotinib decreased both matrix degradation and invasion in the TN breast cancer cell lines MDA-MB 231 and MDA-MB 468. However, and unexpectedly, nilotinib increased by two-fold the invasive properties of the TN breast cancer cell line BT-549 and of Src-transformed fibroblasts. Both display much higher levels of ABL kinase activity compared to MDA-MB 231. Similar effects were obtained by siRNA-mediated down-regulation of ABL expression, confirming ABL central role in this process. ABL anti-tumor effect in BT-549 cells and Src-transformed fibroblasts was not dependent on EGF secretion, as recently reported in neck and squamous carcinoma cells. Rather, we identified the TRIO-RAC1 axis as an important downstream element of ABL activity in these cancer cells. In conclusion, the observation that TN breast cancer cell lines respond differently to ABL inhibitors could have implications for future therapies." @default.
• W2079094787 created "2016-06-24" @default.
• W2079094787 creator A5005586138 @default.
• W2079094787 creator A5018957146 @default.
• W2079094787 creator A5032859567 @default.
• W2079094787 creator A5034113711 @default.
• W2079094787 creator A5040769942 @default.
• W2079094787 creator A5043136683 @default.
• W2079094787 creator A5076971191 @default.
• W2079094787 date "2015-03-24" @default.
• W2079094787 modified "2023-10-18" @default.
• W2079094787 title "ABL Tyrosine Kinase Inhibition Variable Effects on the Invasive Properties of Different Triple Negative Breast Cancer Cell Lines" @default.
• W2079094787 cites W1966240289 @default.
• W2079094787 cites W1969346276 @default.
• W2079094787 cites W1974093434 @default.
• W2079094787 cites W1980116118 @default.
• W2079094787 cites W1981976777 @default.
• W2079094787 cites W1984291872 @default.
• W2079094787 cites W1985617800 @default.
• W2079094787 cites W1986139301 @default.
• W2079094787 cites W1988642004 @default.
• W2079094787 cites W1992773450 @default.
• W2079094787 cites W2001954506 @default.
• W2079094787 cites W2002063867 @default.
• W2079094787 cites W2005978545 @default.
• W2079094787 cites W2012346684 @default.
• W2079094787 cites W2021374902 @default.
• W2079094787 cites W2057370314 @default.
• W2079094787 cites W2065904518 @default.
• W2079094787 cites W2077804275 @default.
• W2079094787 cites W2092522192 @default.
• W2079094787 cites W2095906189 @default.
• W2079094787 cites W2107972068 @default.
• W2079094787 cites W2111093256 @default.
• W2079094787 cites W2117945647 @default.
• W2079094787 cites W2118540283 @default.
• W2079094787 cites W2118893166 @default.
• W2079094787 cites W2145521180 @default.
• W2079094787 cites W2147549467 @default.
• W2079094787 cites W2171312409 @default.
• W2079094787 cites W49724973 @default.
• W2079094787 doi "https://doi.org/10.1371/journal.pone.0118854" @default.
• W2079094787 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4372365" @default.
• W2079094787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25803821" @default.
• W2079094787 hasPublicationYear "2015" @default.
• W2079094787 type Work @default.
• W2079094787 sameAs 2079094787 @default.
• W2079094787 citedByCount "14" @default.
• W2079094787 countsByYear W20790947872015 @default.
• W2079094787 countsByYear W20790947872016 @default.
• W2079094787 countsByYear W20790947872017 @default.
• W2079094787 countsByYear W20790947872018 @default.
• W2079094787 countsByYear W20790947872019 @default.
• W2079094787 countsByYear W20790947872020 @default.
• W2079094787 countsByYear W20790947872021 @default.
• W2079094787 countsByYear W20790947872022 @default.
• W2079094787 crossrefType "journal-article" @default.
• W2079094787 hasAuthorship W2079094787A5005586138 @default.
• W2079094787 hasAuthorship W2079094787A5018957146 @default.
• W2079094787 hasAuthorship W2079094787A5032859567 @default.
• W2079094787 hasAuthorship W2079094787A5034113711 @default.
• W2079094787 hasAuthorship W2079094787A5040769942 @default.
• W2079094787 hasAuthorship W2079094787A5043136683 @default.
• W2079094787 hasAuthorship W2079094787A5076971191 @default.
• W2079094787 hasBestOaLocation W20790947871 @default.
• W2079094787 hasConcept C108636557 @default.
• W2079094787 hasConcept C121608353 @default.
• W2079094787 hasConcept C125418893 @default.
• W2079094787 hasConcept C126322002 @default.
• W2079094787 hasConcept C142669718 @default.
• W2079094787 hasConcept C1491633281 @default.
• W2079094787 hasConcept C184235292 @default.
• W2079094787 hasConcept C2776000893 @default.
• W2079094787 hasConcept C2777413986 @default.
• W2079094787 hasConcept C2777583451 @default.
• W2079094787 hasConcept C2778729363 @default.
• W2079094787 hasConcept C2779536868 @default.
• W2079094787 hasConcept C42362537 @default.
• W2079094787 hasConcept C502942594 @default.
• W2079094787 hasConcept C530470458 @default.
• W2079094787 hasConcept C54355233 @default.
• W2079094787 hasConcept C62478195 @default.
• W2079094787 hasConcept C71924100 @default.
• W2079094787 hasConcept C81885089 @default.
• W2079094787 hasConcept C86803240 @default.
• W2079094787 hasConcept C95444343 @default.
• W2079094787 hasConceptScore W2079094787C108636557 @default.
• W2079094787 hasConceptScore W2079094787C121608353 @default.
• W2079094787 hasConceptScore W2079094787C125418893 @default.
• W2079094787 hasConceptScore W2079094787C126322002 @default.
• W2079094787 hasConceptScore W2079094787C142669718 @default.
• W2079094787 hasConceptScore W2079094787C1491633281 @default.
• W2079094787 hasConceptScore W2079094787C184235292 @default.
• W2079094787 hasConceptScore W2079094787C2776000893 @default.
• W2079094787 hasConceptScore W2079094787C2777413986 @default.
• W2079094787 hasConceptScore W2079094787C2777583451 @default.
• W2079094787 hasConceptScore W2079094787C2778729363 @default.
• W2079094787 hasConceptScore W2079094787C2779536868 @default.

• next